Amphora Discovery Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Amphora Discovery General Information
Description
Provider of pathway-based drug discovery services. The company's lead generation platform delivers unmatched precision, selectivity and data quality, which has produced well characterized proprietary new clinical entities for use in oncology, inflammation, metabolic diseases and neurological disorders. Amphora's most advanced compounds are preclinical candidates in the areas of oncology and inflammation which are exquisitely specific inhibitors for AKT1 and p38 respectively.
Contact Information
Website
www.amphoracorp.comCorporate Office
- 800 Capitola Drive
- Suite 4
- Durham, NC 27713
- United States
Corporate Office
- 800 Capitola Drive
- Suite 4
- Durham, NC 27713
- United States
Amphora Discovery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 21-Oct-2008 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series E) | 01-Feb-2006 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 30-May-2005 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 08-Dec-2004 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Dec-2002 | $23M | $48M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Jan-2001 | $25M | $25M | Completed | Product Development |
Amphora Discovery Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E1 | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 23,750,000 | $0.001000 | $0.08 | $1 | $1 | 1x | $0.71 | 20.22% |
| Series A | 1,300,000 | $0.001000 | $0.08 | $100000 |
Amphora Discovery Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3i Group | PE/Buyout | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Aventis | Corporation | Minority | ||
| CW Group | Venture Capital | Minority | ||
| Chevron Technology Ventures | Corporate Venture Capital | Minority |
Amphora Discovery FAQs
-
When was Amphora Discovery founded?
Amphora Discovery was founded in 2001.
-
Where is Amphora Discovery headquartered?
Amphora Discovery is headquartered in Durham, NC.
-
What industry is Amphora Discovery in?
Amphora Discovery’s primary industry is Drug Discovery.
-
Is Amphora Discovery a private or public company?
Amphora Discovery is a Private company.
-
What is Amphora Discovery’s current revenue?
The current revenue for Amphora Discovery is .
-
How much funding has Amphora Discovery raised over time?
Amphora Discovery has raised $81.9M.
-
Who are Amphora Discovery’s investors?
3i Group, ARCH Venture Partners, Aventis, CW Group, and Chevron Technology Ventures are 5 of 9 investors who have invested in Amphora Discovery.
-
When was Amphora Discovery acquired?
Amphora Discovery was acquired on 21-Oct-2008.
-
Who acquired Amphora Discovery?
Amphora Discovery was acquired by Nanosyn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process